Norman Dovichi of Notre Dame to Speak at Bioanalytical Sensors Mtg, May 22-23, 2014, Cambridge, MA.

Cambridge, MA (PressExposure) March 31, 2014 -- Norman Dovichi, Grace-Rupley Professor at the University of Notre Dame, to give a presentation titled "Zone Electrophoresis-Mass Spectrometry at the zeptomole level," at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA by GTC.

Norman Dovichi received his BS degree in Chemistry and Applied Mathematics from Northern Illinois University and his PhD in Analytical Chemistry from the University of Utah. He played a pioneering role in single molecule detection by laser-induced fluorescence. That experience led to the development of a high-throughput capillary array electrophoresis DNA sequencer. This sequencer was licensed to ABI, who commercialized it as the model 3700 DNA analyzer, which was the workhorse instrument used in the human genome project. Dovichi was the only chemist among a dozen other scientists named as an "Unsung hero" of the human genome project by Science. He has focused his attention on the development of high-sensitivity mass spectrometry for protein analysis.

His group has completed the first comprehensive proteomic study of protein expression changes in single embryos during early stages of development. His group has also developed the highest sensitivity electrospray mass spectrometry interface, which produces 1 zmol detection limits for peptides in tryptic digests, and has demonstrated accurate mass and time tag analysis from 400 fg of an E. coli digest.

This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on the latest discoveries in the Single Cell Analysis field. A balance of both academic and industry experts will facilitate discussion on the following areas:

I. Advances in Sensor Development
II. Clinical Applications of Bioanalytical Sensors
III. Nanopores & Nanochannels
IV. Bio-Electrochemical Sensing
V. Single Molecule Sensing

This conference is also part of the 2014 Drug Discovery Summit, which consists of the following co-located conferences:

1) Single Cell Analysis
2) GPCR Structure, Function, and Drug Discovery
3) Metabolomics: Advances & Applications in Human Disease
4) Bioanalytical Sensors

For more information, please visit

About GTC

GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.

GTC (Global Technology Community), LLC, is a privately held company founded in 2002.

Press Release Source:

Press Release Submitted On: March 31, 2014 at 2:21 am
This article has been viewed 33269 time(s).